These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22423051)

  • 1. Effect of the anti-oxidant tempol on fetal growth in a mouse model of fetal growth restriction.
    Stanley JL; Andersson IJ; Hirt CJ; Moore L; Dilworth MR; Chade AR; Sibley CP; Davidge ST; Baker PN
    Biol Reprod; 2012 Jul; 87(1):25, 1-8. PubMed ID: 22423051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. eNOS knockout mouse as a model of fetal growth restriction with an impaired uterine artery function and placental transport phenotype.
    Kusinski LC; Stanley JL; Dilworth MR; Hirt CJ; Andersson IJ; Renshall LJ; Baker BC; Baker PN; Sibley CP; Wareing M; Glazier JD
    Am J Physiol Regul Integr Comp Physiol; 2012 Jul; 303(1):R86-93. PubMed ID: 22552791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil citrate increases fetal weight in a mouse model of fetal growth restriction with a normal vascular phenotype.
    Dilworth MR; Andersson I; Renshall LJ; Cowley E; Baker P; Greenwood S; Sibley CP; Wareing M
    PLoS One; 2013; 8(10):e77748. PubMed ID: 24204949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic tempol prevents hypertension, proteinuria, and poor feto-placental outcomes in BPH/5 mouse model of preeclampsia.
    Hoffmann DS; Weydert CJ; Lazartigues E; Kutschke WJ; Kienzle MF; Leach JE; Sharma JA; Sharma RV; Davisson RL
    Hypertension; 2008 Apr; 51(4):1058-65. PubMed ID: 18259014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prenatal hypoxia in transgenic mouse models of preeclampsia and fetal growth restriction.
    Rueda-Clausen CF; Stanley JL; Thambiraj DF; Poudel R; Davidge ST; Baker PN
    Reprod Sci; 2014 Apr; 21(4):492-502. PubMed ID: 24084523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of a human IGF-II analog ([Leu27]IGF-II) on fetal growth in a mouse model of fetal growth restriction.
    Charnock JC; Dilworth MR; Aplin JD; Sibley CP; Westwood M; Crocker IP
    Am J Physiol Endocrinol Metab; 2016 Jan; 310(1):E24-31. PubMed ID: 26530156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant Supplementation Modulates Age-Related Placental Bed Morphology and Reproductive Outcome in Mice.
    Silva E; Soares AI; Costa F; Castro JP; Matos L; Almeida H
    Biol Reprod; 2015 Sep; 93(3):56. PubMed ID: 26178715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of resveratrol in pregnancy using murine models with reduced blood supply to the uterus.
    Poudel R; Stanley JL; Rueda-Clausen CF; Andersson IJ; Sibley CP; Davidge ST; Baker PN
    PLoS One; 2013; 8(5):e64401. PubMed ID: 23667712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine artery dysfunction in pregnant ACE2 knockout mice is associated with placental hypoxia and reduced umbilical blood flow velocity.
    Yamaleyeva LM; Pulgar VM; Lindsey SH; Yamane L; Varagic J; McGee C; daSilva M; Lopes Bonfa P; Gurley SB; Brosnihan KB
    Am J Physiol Endocrinol Metab; 2015 Jul; 309(1):E84-94. PubMed ID: 25968580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor 1 signaling in the placenta requires endothelial nitric oxide synthase to support trophoblast function and normal fetal growth.
    Wilson RL; Troja W; Sumser EK; Maupin A; Lampe K; Jones HN
    Am J Physiol Regul Integr Comp Physiol; 2021 May; 320(5):R653-R662. PubMed ID: 33621475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Targeting of a Novel Vasodilator to the Uterine Vasculature to Treat Impaired Uteroplacental Perfusion in Pregnancy.
    Cureton N; Korotkova I; Baker B; Greenwood S; Wareing M; Kotamraju VR; Teesalu T; Cellesi F; Tirelli N; Ruoslahti E; Aplin JD; Harris LK
    Theranostics; 2017; 7(15):3715-3731. PubMed ID: 29109771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sildenafil citrate treatment in the eNOS knockout mouse model of fetal growth restriction on long-term cardiometabolic outcomes in male offspring.
    Mills V; Plows JF; Zhao H; Oyston C; Vickers MH; Baker PN; Stanley JL
    Pharmacol Res; 2018 Nov; 137():122-134. PubMed ID: 30292428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine growth retardation in endothelial nitric oxide synthase-deficient mice is established from early stages of pregnancy.
    Pallares P; Gonzalez-Bulnes A
    Biol Reprod; 2008 Jun; 78(6):1002-6. PubMed ID: 18256327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil citrate rescues fetal growth in the catechol-O-methyl transferase knockout mouse model.
    Stanley JL; Andersson IJ; Poudel R; Rueda-Clausen CF; Sibley CP; Davidge ST; Baker PN
    Hypertension; 2012 May; 59(5):1021-8. PubMed ID: 22392899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distal-less 3 haploinsufficiency results in elevated placental oxidative stress and altered fetal growth kinetics in the mouse.
    Clark PA; Brown JL; Li S; Woods AK; Han L; Sones JL; Preston RL; Southard TL; Davisson RL; Roberson MS
    Placenta; 2012 Oct; 33(10):830-8. PubMed ID: 22819041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crossing mice deficient in eNOS with placental-specific Igf2 knockout mice: a new model of fetal growth restriction.
    Dilworth MR; Kusinski LC; Baker BC; Renshall LJ; Baker PN; Greenwood SL; Wareing M; Sibley CP
    Placenta; 2012 Dec; 33(12):1052-4. PubMed ID: 23099110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin Receptor A Antagonism and Fetal Growth in Endothelial Nitric Oxide Synthase Gene Knockout Maternal and Fetal Mice.
    Luo K; Thaete LG; Neerhof MG
    Reprod Sci; 2016 Aug; 23(8):1028-36. PubMed ID: 26791973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Acetylcysteine, a glutathione precursor, reverts vascular dysfunction and endothelial epigenetic programming in intrauterine growth restricted guinea pigs.
    Herrera EA; Cifuentes-Zúñiga F; Figueroa E; Villanueva C; Hernández C; Alegría R; Arroyo-Jousse V; Peñaloza E; Farías M; Uauy R; Casanello P; Krause BJ
    J Physiol; 2017 Feb; 595(4):1077-1092. PubMed ID: 27739590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal programming of blood pressure in a transgenic mouse model of altered intrauterine environment.
    Chiossi G; Costantine MM; Tamayo E; Hankins GD; Saade GR; Longo M
    J Physiol; 2016 Dec; 594(23):7015-7025. PubMed ID: 27506899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II decreases nitric oxide synthase 3 expression via nitric oxide and superoxide in the thick ascending limb.
    Ramseyer VD; Garvin JL
    Hypertension; 2009 Feb; 53(2):313-8. PubMed ID: 19075094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.